Just-released results from the bi-annual Global Salary Survey for HEOR & Market Access by HealthEconomics.Com show that 2017 median annual base salaries, excluding bonuses and benefits, experienced big growth in certain job titles and areas of focus, while other areas held steady.
The survey is based on 456 respondents, representing 200-plus organizations, 36 countries, and every major job sector employing healthcare value researchers. HealthEconomics.Com undertakes this extensive survey in order to encourage transparent, optimal, and fair compensation for this important segment of the healthcare industry. We ask hard questions, like is there gender or ethnic bias in salaries, and what countries pay the highest or lowest for similar jobs. Thank you for being part of the conversation!
Salary growth mirrors the industry focus on value-based real-world research to achieve market access through innovative pricing and reimbursement strategies, as well as the burgeoning medical device field. Overall, Biopharma sector salaries for HEOR held steady over 2015 (but grew in Pricing & Reimbursement, Market Access, and Medical Affairs), while respondents working for CROs reported slightly lower salaries in 2017 vs 2015, on average. Salary growth was positive for HEOR-oriented employees in the MarComm agencies, indicating the importance of well-crafted communication tools containing value-based research.
In terms of salaries by position, individuals holding the title of Vice President with HEOR responsibilities saw a 12% increase in median salary, while Manager level salaries decreased 12%. Does this suggest the importance of HEOR/MA employees getting those C-Suite skills in order to get big salary growth? We think so. Job titles holding steady since 2015 include Director (all levels), Analyst, and Health Outcomes Liaison.